AI summary · may contain errors
COVID-19 and active tuberculosis show distinct maturation-associated neutrophil transcriptional programs, with 45.2% of 770 curated genes differing in response magnitude between diseases.
- Open access
Moving in bioRxiv, The Lancet Microbe, European Respiratory Journal, JAMA, medRxiv, JACC: Basic to Translational Science, JAMA Internal Medicine and Journal of Allergy and Clinical Immunology.
Rebuilt
Nothing in this topic has moved yet this week.
Newest first · last 60 days
AI summary · may contain errors
COVID-19 and active tuberculosis show distinct maturation-associated neutrophil transcriptional programs, with 45.2% of 770 curated genes differing in response magnitude between diseases.
AI summary · may contain errors
A study links post–COVID-19 vaccination fever to differences in the gut microbiome, suggesting microbiome features may be associated with who runs a fever.
AI summary · may contain errors
Loss of phosphorylation at conserved spike residue Y674 (Y674F) ablates S1/S2 cleavage on virions and reduces TMPRSS2-dependent entry, especially in human airway cells.
AI summary · may contain errors
Intramuscular SARS-CoV-2 priming in UK adults aged 50+ did not induce de novo nasal anti-spike IgA after one or two doses across 28- or 84-day schedules.
AI summary · may contain errors
In a hamster model of SARS-CoV-2 infection, combining Poly IC and FK506 suppresses viral load and lung injury across Beta, Delta, and EG.1 variants, reducing mortality and severe illness.
AI summary · may contain errors
Long COVID participants (n = 73) show higher symptom scores and impaired endothelial reactivity than matched controls (n = 41), alongside increased pMLKL and LC3 in immune and endothelial cells.
AI summary · may contain errors
After three COVID-19 vaccine doses, vaccine effectiveness against SARS-CoV-2 infection with pre-omicron variants was 82·3% (95% CI 72·4–88·7) in adults on immunosuppressive therapies.
AI summary · may contain errors
Vaccination status is significantly associated with faster symptom resolution for Long COVID in a cohort of 303 people infected with SARS-CoV-2 during Zambia’s 3rd wave, with aHR=1.71.
AI summary · may contain errors
TMEM106B is required for ACE2-independent SARS-CoV-2 S-E484D infection in NCI-H522 and NCI-H661 airway-derived cells, with TMEM106B knockout completely abolishing infection.
AI summary · may contain errors
Three groups of RBD-specific monoclonal antibodies against HCoV-HKU1 define distinct epitope footprints within and around the TMPRSS2 receptor-binding site, yet neutralization depends on cell context.
AI summary · may contain errors
Empirical antibiotic use in hospitalised COVID-19 patients is linked to higher 28-day in-hospital mortality, with adjusted hazard ratios of 1·80 in mild-to-moderate and 1·16 in severe-to-critical cases.
AI summary · may contain errors
The European Respiratory Journal clinical practice guideline for long COVID prevention and treatment provides timely recommendations, but evidence remains limited, heterogeneous, and often low-certainty.
AI summary · may contain errors
In SARS-CoV-2–infected mice, sex differences in PASC emerge after viral clearance, with females showing persistent cognitive deficits and heightened neuroinflammation linked to X-linked TLR7 signaling.
AI summary · may contain errors
Defining comorbidities before SARS-CoV-2 infection instead of before Long COVID diagnosis in 6,130,413 U.S. adults yields 8%–314% higher adjusted attributable risks across 16 comorbidities.
AI summary · may contain errors
Adults with autoimmune rheumatic diseases had a higher Long COVID prevalence (2.8% vs 1.5%) and increased risk (aHR 1.56, 95% CI 1.45–1.67) in a matched N3C cohort.
AI summary · may contain errors
Prior mild SARS-CoV-2 BA.1 infection protects mice from lethal heterologous Delta challenge equally in males and females, but via sex-divergent immune mechanisms.
AI summary · may contain errors
Intranasal trimeric nanobody A8 in golden Syrian hamsters sustains respiratory exposure with minimal systemic absorption and improves outcomes after SARS-CoV-2 B.1.351 challenge.
AI summary · may contain errors
Holding biologic or targeted synthetic DMARD therapy for 2 weeks around a supplemental COVID-19 mRNA dose did not significantly change SARS-CoV-2 spike IgG GMFR (hold/continue GMFR ratio 0.96).
AI summary · may contain errors
ACE2 loss is observed in organs of COVID-19 patients and in SARS-CoV-2-infected cells, and in aged obese-diabetic mice it is linked to greater morbidity and persistent pulmonary infection.
Journals this month
Topics moving, week to 17 Nov 2026
By field